Product image of Midanium (Midazolam) supplied by GNH India

Midanium

Active Ingredient:
Midazolam
Origin:
EU

Midanium (Midazolam)

Midazolam, the active ingredient in Midanium, is a benzodiazepine presented as a sterile injectable solution for intramuscular, intravenous, and rectal use. It provides rapid sedation, anxiolysis, muscle relaxation, and anticonvulsant effects for patients undergoing procedures, anesthesia induction or experiencing acute seizures.

GNH India supplies Midanium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and offers reliable global distribution. Its supply chain includes temperature‑controlled logistics where required, ensuring product integrity from manufacture to end‑user.

Manufacturer / TM Owner

Zaklady Farmaceutyczne Polpharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midazolam is a benzodiazepine that provides sedation and seizure control across several clinical pathways.

  • Procedural sedation: produces calmness and amnesia for minor surgical or diagnostic procedures.
  • Induction of anesthesia: facilitates rapid loss of consciousness before general anesthetic agents.
  • Pre‑operative anxiolysis: reduces anxiety and muscle tension before surgery.
  • Status epilepticus: terminates ongoing seizure activity when other treatments fail.
  • Acute seizure control: provides prompt seizure cessation in emergency settings.

How It Works

  • Midazolam binds to the benzodiazepine site on the GABAA receptor complex, increasing the frequency of chloride channel opening in response to GABA. This potentiates inhibitory neurotransmission, leading to hyperpolarization of neuronal membranes and resulting in sedative, anxiolytic, muscle‑relaxant and anticonvulsant effects. The enhanced GABAergic activity also depresses central nervous system reflexes, contributing to its rapid onset of action when administered intravenously or intramuscularly.

Side Effects

Midazolam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness
  • Dizziness
  • Amnesia
  • Headache
  • Nausea
  • Hypotension

Serious or Rare Side Effects

  • Respiratory depression
  • Severe hypotension
  • Paradoxical agitation
  • Anaphylactic reaction
  • Skin rash or Stevens‑Johnson syndrome

Precautions & Warnings

When using Midanium, clinicians should observe several safety measures to minimize risk.

  • Assess respiratory function: monitor breathing rate and oxygen saturation before and during administration.
  • Monitor cardiovascular status: watch blood pressure and heart rate for hypotension or arrhythmia.
  • Use caution in the elderly: lower doses may be required due to increased sensitivity.
  • Avoid abrupt discontinuation: taper the drug to prevent withdrawal symptoms.
  • Adjust dose in hepatic impairment: reduced clearance may prolong effects.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Midazolam can interact with other substances that affect the central nervous system or its metabolism.

Major Interactions (Avoid)

  • Opioids: combined use can cause profound respiratory depression.
  • Alcohol: additive CNS depression may lead to oversedation.
  • Barbiturates: synergistic depressant effects increase risk of coma.
  • General anesthetics: may enhance sedation and delay recovery.
  • CNS depressant antihistamines: increase drowsiness and impair coordination.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise midazolam plasma levels.
  • CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce efficacy.
  • Antifungal agents (e.g., fluconazole): can increase sedative effect.
  • Certain antidepressants (e.g., fluoxetine): may potentiate CNS depression.
  • Antihypertensive drugs: additive hypotensive effect may require monitoring.

Frequently Asked Questions

Midanium contains midazolam, a short‑acting benzodiazepine used for procedural sedation, induction of general anesthesia, pre‑operative anxiolysis, and rapid control of seizures such as status epilepticus or acute seizure episodes in hospital settings.

Midazolam enhances the activity of the neurotransmitter GABA at the GABAA receptor, increasing chloride ion influx. This amplifies inhibitory signaling in the brain, producing sedation, anxiolysis, muscle relaxation, and anticonvulsant effects.

The appropriate dose of Midanium is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and route of administration. Dosing guidelines are provided in the product’s prescribing information and should be individualized for each patient.

Safety data for midazolam in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the Midanium product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Midazolam has a faster onset and shorter duration of action compared with agents such as diazepam or lorazepam, making it preferable for procedural sedation and rapid seizure control. Its potency and rapid metabolism allow quick titration, whereas longer‑acting benzodiazepines are often chosen for chronic anxiety or seizure prophylaxis.

Midanium should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability and sterility.

Midanium is supplied as a sterile injectable solution and can be given intramuscularly, intravenously, or rectally, depending on the clinical situation and the prescriber’s judgment. Administration techniques follow standard aseptic practices for injectable medications.

The most critical adverse events include respiratory depression, severe hypotension, paradoxical agitation, and rare allergic reactions such as anaphylaxis or severe skin eruptions. Continuous monitoring of breathing and cardiovascular status is essential, especially when higher doses or concurrent depressant drugs are used.

Midanium is contraindicated in patients with known hypersensitivity to midazolam or any benzodiazepine, and in individuals with severe acute narrow‑angle glaucoma. Caution is also advised for patients with significant respiratory compromise, severe hepatic impairment, or those taking interacting CNS depressants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Midazolam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT